Longitudinal increases in mitochondrial DNA levels in blood cells are associated with survival in critically ill patients.
BACKGROUND
Mitochondrial dysfunction may be causally related to the pathogenesis of organ failure in critically ill patients. Decreased mitochondrial DNA (mtDNA) levels have been associated with mitochondrial dysfunction and were investigated here in relation to short-term (31-day) survival.


METHODS
This was a prospective longitudinal cohort study of 28 mechanically ventilated critically ill adults admitted to a single center tertiary care intensive care unit (ICU) with hypotension secondary to cardiogenic (N = 13), septic (N = 14) or hypovolemic (N = 1) disease processes. Clinical data and blood were collected at baseline and patients were followed until they expired or left the ICU. Blood was collected every Monday, Wednesday and Friday, and the buffycoat relative mtDNA/nuclear DNA (nDNA) ratio was determined. An archived pool of healthy controls was also studied.


RESULTS
At baseline, the patients' mtDNA/nDNA ratio was 30% lower than a pool of 24 healthy controls (0.76 versus 1.09) and was not different between short-term survivors and non-survivors (0.74 +/- 0.05 (N = 16) versus 0.79 +/- 0.06 (N = 12), p = 0.49). By day 4, the percent mtDNA/nDNA change from baseline in survivors was significantly different from that in non-survivors (+29.5% versus -5.7%, p = 0.03). It also tended to be higher in survivors at last measurement (+38.4% versus +7.1%, p = 0.06). There was a weak correlation between within patient mtDNA/nDNA and platelet count (r = 0.20, p = 0.03) but not with Sequential Organ Failure Assessment (SOFA) scores (r = 0.12, p = 0.23). The mtDNA associations remained after adjustment for platelet.


CONCLUSIONS
Blood mtDNA levels appeared initially low, increased over time in patients who ultimately survived, and remained low in those who did not. This is consistent with mitochondrial recovery being associated with survival and warrants further investigation as a marker of mitochondrial alterations and outcome in critical illness.
Côté
Hélène C F
HC
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada V6T 2B5. helene.cote@ubc.ca
Day
Andrew G
AG
Heyland
Daren K
DK
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D001773:Blood Cells / Q000378:metabolism*; D002170:Canada / Q000453:epidemiology; D015331:Cohort Studies; D016638:Critical Illness / Q000401:mortality*; D004272:DNA, Mitochondrial / Q000097:blood*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D011446:Prospective Studies; D016019:Survival Analysis
D015415:Biomarkers; D004272:DNA, Mitochondrial
N Engl J Med. 2002 Mar 14;346(11):811-20
11893792
Intensive Care Med. 1999 Jul;25(7):686-96
10470572
JPEN J Parenter Enteral Nutr. 2007 Mar-Apr;31(2):109-18
17308251
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5618-23
15800038
Am J Respir Crit Care Med. 2003 Feb 15;167(4):570-9
12480607
Nucleic Acids Res. 2003 Jun 1;31(11):e61
12771225
Curr Infect Dis Rep. 2003 Oct;5(5):365-371
13678565
Crit Care Med. 2002 Feb;30(2):276-84
11889292
Science. 1964 Mar 27;143(3613):1457-9
14107454
Curr Biol. 2001 Mar 6;11(5):361-5
11267874
Crit Care Clin. 2002 Jan;18(1):165-75
11910729
Intensive Care Med. 2005 Mar;31(3):327-37
15605227
Lancet. 2002 Jul 20;360(9328):219-23
12133657
Lancet. 2005 Jan 1-7;365(9453):53-9
15639679
Crit Care Med. 2006 Sep;34(9):2439-46
16791110
J Am Coll Surg. 2006 Mar;202(3):407-17
16500244
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Sep;18(9):554-7
16959157
N Engl J Med. 1994 Jun 16;330(24):1717-22
7993413
J Infect Dis. 2003 Jun 15;187(12):1972-6
12792876
Eur J Med Res. 2004 Aug 31;9(8):371-7
15337626
J Mol Cell Cardiol. 2004 Jan;36(1):141-50
14734056
Shock. 2006 Nov;26(5):430-7
17047512
Mitochondrion. 2004 Sep;4(5-6):729-41
16120428
N Engl J Med. 2001 Nov 8;345(19):1359-67
11794168
FASEB J. 2005 Sep;19(11):1531-3
15994412
J Cell Physiol. 2007 May;211(2):364-70
17219405
Ann N Y Acad Sci. 2002 Apr;959:214-37
11976198
Biochem Biophys Res Commun. 1988 Sep 30;155(3):1360-5
3178814
Am J Respir Crit Care Med. 1999 Oct;160(4):1347-53
10508827
Nature. 2005 Oct 13;437(7061):1032-7
16136080
Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E1044-50
16803854
Adv Exp Med Biol. 2003;530:725-36
14562771
Shock. 1996;6 Suppl 1:S23-6
8828094
Biochem Soc Trans. 2004 Dec;32(Pt 6):1070-1
15506967
Crit Care Med. 1985 Oct;13(10):818-29
3928249